Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
80,553,035
-
Share change
-
-860,198
-
Total reported value
-
$1,168,812,560
-
Put/Call ratio
-
4.2%
-
Price per share
-
$14.51
-
Number of holders
-
191
-
Value change
-
-$19,067,888
-
Number of buys
-
94
-
Number of sells
-
80
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2022
As of 31 Dec 2022,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,553,035 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Camber Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, EARNEST PARTNERS LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, DIMENSIONAL FUND ADVISORS LP, and DISCIPLINED GROWTH INVESTORS INC /MN.
This page lists
191
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.